Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering

July 11, 2026 - 00:09

BEIJING -- Haoxi Health Technology Ltd, a company listed on the NASDAQ under the ticker HAO, has announced a registered direct offering expected to raise approximately $4 million. The deal involves the sale of 10 million of the company's Class A Ordinary Shares, each with a par value of $0.32.

Under the terms of the agreement with certain investors, the shares are priced at $0.40 each. The company also offered pre-funded warrants as an alternative to direct shares for investors. The purchase price for these warrants is set at a nominal amount, effectively allowing investors to secure the underlying shares at the same $0.40 price point upon exercise.

Haoxi Health Technology focuses on providing digital marketing and health-related services. The company plans to use the net proceeds from this offering for general corporate purposes and working capital. The transaction is expected to close shortly, pending the satisfaction of customary closing conditions. This capital raise provides the company with additional financial flexibility as it continues to operate in the competitive health technology sector.